The effect of silencing NKG2D through RNA interference on receptor functions in interleukin-2-activated human natural killer cells
- PMID: 17043026
The effect of silencing NKG2D through RNA interference on receptor functions in interleukin-2-activated human natural killer cells
Abstract
Natural killer (NK) cells are effectors of the innate immunity involved in tumor surveillance. NKG2D is a potent activating receptor eliciting cytokine and cytolytic NK responses upon recognition of tumor-associated ligands. We engineered primary interleukin (IL)-2-activated human NK cells to express constitutively low levels of NKG2D by lentiviral delivery of small interfering RNA. NKG2D-mediated effector functions were strongly impaired in NKG2D(low) NK cells. Reduction of NKG2D surface expression to 15%, corresponding to receptor levels in resting NK cells, rendered cells fully insensitive to NKG2D triggering. These data underscore the importance of NKG2D receptor cell surface density and suggest a threshold of expression for optimal reactivity of human NK cells.
Similar articles
-
RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.Cancer Res. 2004 Oct 15;64(20):7596-603. doi: 10.1158/0008-5472.CAN-04-1627. Cancer Res. 2004. PMID: 15492287
-
Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.Cancer Res. 2005 Jul 15;65(14):6321-9. doi: 10.1158/0008-5472.CAN-04-4252. Cancer Res. 2005. PMID: 16024634
-
Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells.J Leukoc Biol. 2007 Nov;82(5):1322-31. doi: 10.1189/jlb.1106699. Epub 2007 Aug 21. J Leukoc Biol. 2007. PMID: 17711975
-
Imbalance of NKG2D and its inhibitory counterparts: how does tumor escape from innate immunity?Int Immunopharmacol. 2005 Jul;5(7-8):1099-111. doi: 10.1016/j.intimp.2005.03.003. Epub 2005 Apr 1. Int Immunopharmacol. 2005. PMID: 15914316 Review.
-
NKG2D and cytotoxic effector function in tumor immune surveillance.Semin Immunol. 2006 Jun;18(3):176-85. doi: 10.1016/j.smim.2006.03.005. Epub 2006 May 3. Semin Immunol. 2006. PMID: 16675266 Review.
Cited by
-
Systematic improvements in lentiviral transduction of primary human natural killer cells undergoing ex vivo expansion.Mol Ther Methods Clin Dev. 2021 Jan 20;20:559-571. doi: 10.1016/j.omtm.2021.01.008. eCollection 2021 Mar 12. Mol Ther Methods Clin Dev. 2021. PMID: 33665226 Free PMC article.
-
Charge-altering releasable transporters enable phenotypic manipulation of natural killer cells for cancer immunotherapy.Blood Adv. 2020 Sep 8;4(17):4244-4255. doi: 10.1182/bloodadvances.2020002355. Blood Adv. 2020. PMID: 32898247 Free PMC article.
-
Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies.Stem Cell Res Ther. 2020 Jun 16;11(1):234. doi: 10.1186/s13287-020-01741-4. Stem Cell Res Ther. 2020. PMID: 32546200 Free PMC article. Review.
-
Stress-Induced In Vivo Recruitment of Human Cytotoxic Natural Killer Cells Favors Subsets with Distinct Receptor Profiles and Associates with Increased Epinephrine Levels.PLoS One. 2015 Dec 23;10(12):e0145635. doi: 10.1371/journal.pone.0145635. eCollection 2015. PLoS One. 2015. PMID: 26700184 Free PMC article. Clinical Trial.
-
Genetic Manipulation of NK Cells for Cancer Immunotherapy: Techniques and Clinical Implications.Front Immunol. 2015 Jun 10;6:266. doi: 10.3389/fimmu.2015.00266. eCollection 2015. Front Immunol. 2015. PMID: 26113846 Free PMC article. Review.